2015-06-03

[DIV28SUPER] NIDA Neuroscience Update June 3, 2015



Table of Contents

 

I.    Request for Information: NIH Precision Medicine Cohort - Strategies to Address Community Engagement and Health Disparities NOT-OD-15-107 http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-107.html

 

II.     Harnessing Genome Editing Technologies to Functioning Validate Genetic Variants in Substance Use Disorders (R21/R33) RFA-DA-16-004 http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-004.html

 

III.    Identification of Genetic and Genomic Variants by Next-Gen Sequencing in Non-human Animal Models (U01)  http://grants.nih.gov/grants/guide/pa-files/PAR-15-120.html#sthash.bBPhto89.dpuf

 

IV.    Rat Genetics and Genomics for Psychiatric Disorders and Addiction Workshop  June 29, 2015, University of Chicago, Chicago, IL http://ratgenes.org/register/ 

 

V.     Short Course on the Genetics of Addiction August 24-30, 2015, Bar Harbor, ME   http://courses.jax.org/2015/addiction.html   Application deadline: July 24, 2015

 

 

 

 

I.              Request for Information: NIH Precision Medicine Cohort - Strategies to Address Community Engagement and Health Disparities NOT-OD-15-107 http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-107.html

 

Response Date: June 19, 2015



National Institutes of Health (NIH)

 

Purpose

This Request for Information (RFI) seeks feedback to help guide creating the National Institutes of Health (NIH)'s national research cohort of 1 million or more Americans as part of the President's proposed Precision Medicine Initiative (PMI), specifically as it relates to the development and implementation of effective community engagement strategies for the cohort, and to the advancement the cohort's ability to conduct transformative research to address health disparities. Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle. In order for the benefits of precision medicine and the PMI to be available to all people, including those who are medically underserved and/or historically underrepresented in biomedical research, or who, for reasons of systematic social disadvantage experience disparities in health, the NIH aims to assemble a cohort reflective of the rich diversity of the U.S. population.

Please see full notice for information requested http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-107.html and how to respond to RFI by June 19, 2015.

Please direct all inquiries to:
pmicommunityengagementrfi@mail.nih.gov

--------------------------------------------------------------------------------------------------------------------

II.             Harnessing Genome Editing Technologies to Functioning Validate Genetic Variants in Substance Use Disorders (R21/R33) RFA-DA-16-004 http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-004.html

 

Funding Opportunity Purpose

The purpose of this initiative is to harness genome or epigenome editing technologies to functionally validate and characterize genetic or epigenetic variants involved in substance use disorders.  The purpose is also that the genetic resources generated will be made broadly available to the scientific community to probe more deeply into the neurobiological mechanisms involved in the function of a variant, gene, or pathway and provide critical foundational knowledge for the development of future prevention, diagnostic, and therapeutic strategies.

Please see full announcement for details. http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-004.html

Scientific/Research Contact(s):

 

John Satterlee, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1020
Email: satterleej@nida.nih.gov

-----------------------

III.            Identification of Genetic and Genomic Variants by Next-Gen Sequencing in Non-human Animal Models (U01)  http://grants.nih.gov/grants/guide/pa-files/PAR-15-120.html#sthash.bBPhto89.dpuf

Next due dates: June 30, 2015; October 20, 2015

 

The goals of this initiative are to identify gene variants of traits associated with addiction and substance abuse in selectively bred, and outbred  non-human animal models using methodologies of Next Gen-Sequencing, mapping, and genotyping.

 

This FOA will replace PAR-14-010 "Identification of Gene Variants for Addiction Related Traits by Next-Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3)".

See complete announcement  at: http://grants.nih.gov/grants/guide/pa-files/PAR-15-120.html#sthash.bBPhto89.dpuf

--------------------

 

IV.            Rat Genetics and Genomics for Psychiatric Disorders and Addiction Workshop

 

Will be held on Monday, June 29, 2015,   University of Chicago.

Poster session: three winners of best posters will win $300.

Registration is free. For more information and to register please go to ratgenes.org/register

 Speakers:

Amelie Baud, Ph.D., EMBL - European Bioinformatics Institute

Mark S. Brodie, Ph.D., University of Illinois at Chicago

Aron Geurts, Ph.D., Medical College of Wisconsin

David Goldman, M.D., NIAAA

David Jentsch, Ph.D., Ph.D., UCLA

Thomas Jhou, Ph.D., Medical University of South Carolina

Paul J. Kenny, Ph.D., School of Medicine at Mount Sinai

Margaret McCarthy, Ph.D., University of Maryland School of Medicine

Abraham A. Palmer, Ph.D., University of Chicago

Daniel McGehee, Ph.D., University of Chicago

Celeste Napier, Ph.D., Rush University Medical Center

Subhash C. Pandey, Ph.D., University of Illinois at Chicago

Marina Wolf, Ph.D., Rosalind Franklin University of Medicine and Science

 

 

 

V.             Short Course on the Genetics of Addiction: 

Supported by National Institute on Drug Abuse Grant – DA032192, The Howard Hughes Medical Institute, LabDiet and TestDiet

Application deadline: July 24, 2015

Date: August 24-30, 2015

Location: The Jackson Laboratory in Bar Harbor, Maine

Website: http://courses.jax.org/2015/addiction.html  

 Scholarships are available!

This course emphasizes genetic applications and approaches to drug addiction research through methodological instruction based on literature, data sets and informatics resources drawn from studies of addiction related phenotypes. The course includes plenary sessions on major progress in addiction genetics, and discussion sessions in which students present their work for discussion on applications of genetic methods. Students will leave the course able to design and interpret genetic and genomic studies of addiction as they relate to their specific research question, and will be able to make use of current bioinformatics resources to identify research resources and make use of public data sources in their own research.

 For more information or to apply for this event, please go to http://courses.jax.org/2015/addiction.html   or contact Erin McDevitt; erin.mcdevitt@jax.org or 207-288-6659

 

Erin McDevitt

Senior Events & Meetings Planner

207.288.6659 t  |  207.288.6080 f

erin.mcdevitt@jax.org

 

 -----------------------------------

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309

 

No comments:

Post a Comment